April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The Protective Role of AMPK/SIRT1/PGC-1α Signalling in Retinal Astrocytes
Author Affiliations & Notes
  • Qi Jiang
    Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
    Vision Science, Toronto Western Research Institute, Toronto, ON, Canada
  • John G Flanagan
    Vision Science, Toronto Western Research Institute, Toronto, ON, Canada
    Ophthalmology and Vision Science, University of Toronto, Toronto, ON, Canada
  • Darren Chan
    Vision Science, Toronto Western Research Institute, Toronto, ON, Canada
  • Jeremy M Sivak
    Vision Science, Toronto Western Research Institute, Toronto, ON, Canada
    Ophthalmology and Vision Science, University of Toronto, Toronto, ON, Canada
  • Footnotes
    Commercial Relationships Qi Jiang, None; John Flanagan, None; Darren Chan, None; Jeremy Sivak, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2270. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qi Jiang, John G Flanagan, Darren Chan, Jeremy M Sivak; The Protective Role of AMPK/SIRT1/PGC-1α Signalling in Retinal Astrocytes. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2270.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The transcriptional co-activator PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1 alpha) is a key regulator of energy metabolism and oxidative stress response. When activated by upstream regulators such as AMP kinase (AMPK) and sirtuin 1 (SIRT1), PGC-1α modulates the expression of genes including those involved in antioxidant defense. We have previously found that the loss of PGC-1α compromised retinal ganglion cell (RGC) homeostasis and induced pathological astrocyte reactivity. We aim to determine whether promoting activity through the AMPK/SIRT1/PGC-1α pathway in astrocytes can increase their resistance to oxidative stress and ultimately enhance their ability to support the RGCs.

Methods: In vitro experiments were performed using primary rat retinal astrocytes and an astrocytic cell line (A7). After exposure to oxidative stress, the level or activation of AMPK, SIRT1, and PGC-1α was determined by Western blot. To evaluate whether stimulating the pathway offers protection, pharmacological agonists of AMPK (AICA-Riboside, AICAR) and SIRT1 (SRT1720) were applied to A7 cells under oxidative stress. Cell viability was then assessed by a colorimetric XTT assay. Subsequently, the expression of several PGC-1α-regulated genes was analyzed after treatment to determine downstream targets that are significantly regulated.

Results: Following oxidative stress, increased phosphorylation of AMPK and elevated nuclear levels of SIRT1 and PGC-1α were evident. Treatment with AICAR and SRT1720 was able to significantly improve cell viability in a dose dependent manner (p<0.05). Combined treatment with both compounds further increased viability compared to either alone. Lastly, analysis of gene expression revealed the upregulation of antioxidant genes, including a two- to three-fold increase in superoxide dismutase 1 (SOD1), in response to AMPK and SIRT1 activation.

Conclusions: The AMPK/SIRT1/PGC-1α axis is stimulated when astrocytes are challenged by oxidative stress. Through pharmacological activation of AMPK and SIRT1, astrocytes exhibit increased resistance against oxidative insult through the expression of antioxidant defense genes.

Keywords: 429 astrocyte • 634 oxidation/oxidative or free radical damage • 715 signal transduction: pharmacology/physiology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×